Valuation: genedrive plc

Market Cap 20.87M 27.64M 24.25M 22.9M 39.07M 2.65B 39.35M 274M 106M 1.35B 104M 102M 4.35B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.07M 22.88M 21.61M 36.86M 2.5B 37.12M 259M 100M 1.28B 97.89M 95.77M 4.1B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.41%
Yield 2024 *
-
Yield 2025 -
1 day+2.13%
1 week-4.00%
Current month-14.29%
1 month-9.43%
3 months-7.69%
6 months+14.29%
Current year+37.14%
1 week 1.15
Extreme 1.15
1.25
1 month 1.15
Extreme 1.15
1.55
Current year 0.75
Extreme 0.75
1.55
1 year 0.21
Extreme 0.21
1.55
3 years 0.19
Extreme 0.19
13.5
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-05
Director of Finance/CFO 48 2022-04-06
Director TitleAgeSince
Chairman 80 2026-07-12
Director/Board Member 67 2026-08-31
Director/Board Member 56 2023-09-10
Date Insider Type Main position Quantity % Market Cap. Importance
12/20/24 Buy

Chief Financial Officer

1,000,000 0.1841%
12/20/24 Free 400,000 0.0736%
12/20/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%-4.00%+433.33%-87.69% 25.51M
-2.64%+4.45%+33.32%-20.08% 18.3B
-5.20%-1.82%-37.80%+27.36% 1.85B
0.00%+0.41%-29.94%+14.31% 868M
-0.11%-0.22%+52.99%-0.70% 778M
+2.34%+3.01%-61.38%-84.57% 750M
-0.69%+7.10%-29.30%-46.50% 686M
+1.77%+6.49%-40.19%-52.51% 590M
-0.69%+8.64%+42.82%+87.54% 473M
+5.05%+7.11%+0.34%+11.48% 420M
Average +0.20%+3.12%+36.42%-15.14% 2.47B
Weighted average by Cap. -2.18%+3.89%+20.07%-15.66%

Financials

2024 2025
Net sales 501K 663K 582K 550K 938K 63.58M 945K 6.58M 2.55M 32.48M 2.49M 2.44M 104M 954K 1.26M 1.11M 1.05M 1.79M 121M 1.8M 12.53M 4.85M 61.85M 4.74M 4.64M 199M
Net income -7.08M -9.37M -8.22M -7.76M -13.24M -898M -13.34M -92.9M -35.98M -459M -35.17M -34.41M -1.47B -5.23M -6.93M -6.08M -5.74M -9.79M -664M -9.86M -68.69M -26.6M -339M -26M -25.44M -1.09B
Net Debt -5.17M -6.84M -6.01M -5.67M -9.68M -656M -9.75M -67.87M -26.29M -335M -25.7M -25.14M -1.08B -1.18M -1.57M -1.37M -1.3M -2.21M -150M -2.23M -15.52M -6.01M -76.63M -5.88M -5.75M -246M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26-09-25 GBX 1.200 +2.13% 2,145,325
26-09-24 GBX 1.175 -2.08% 3,603,057
26-09-23 GBX 1.200 +4.35% 2,881,128
26-09-22 GBX 1.150 -6.12% 1,498,355
26-09-21 GBX 1.225 -2.00% 6,344,456

Annual profits - Rate of surprise